+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Panuveitis Treatment Market Report 2025 - Product Thumbnail Image

Panuveitis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Pediatric Medicines: Global Markets - Product Thumbnail Image

Pediatric Medicines: Global Markets

  • Report
  • November 2019
  • 169 Pages
  • Global
From
From
From
From
From
From
Skeletal Dysplasia Market - Product Thumbnail Image

Skeletal Dysplasia Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Pruritus Therapeutics Market Report 2025 - Product Thumbnail Image

Pruritus Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Lower Respiratory Tract Therapeutics Market Report 2025 - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nasal Polyps Treatment Market Report 2025 - Product Thumbnail Image

Nasal Polyps Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-Cancer MAbS Market Report 2025 - Product Thumbnail Image

Anti-Cancer MAbS Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Loading Indicator